STXBP1, SYNGAP1, and WDR45, which are canonical epilepsy genes, were among the predicted targets, suggesting that tsRNAs may contribute to the broader molecular landscape underlying disease susceptibility (Zhang et al. 2024). This evidence concerns the gene WDR45 and epilepsy.